VARNOTECH
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses. It was founded in 2019.
VARNOTECH
Industry:
Intellectual Property Medical Product Research
Founded:
2019-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.varnotech.com.cn
Status:
Active
Email Addresses:
[email protected]
Total Funding:
730 M CNY
Similar Organizations
ArtisanBio
ArtisanBio is provider of cell engineering and data analysis solutions that advance the cell therapy revolution.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
ExpressCells
ExpressCells creates custom cell lines for biological research and drug discovery.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Precision Biotechnology
Precision Biotechnology specializes in the development of immune cell preparations and application technologies for cancer patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Vaxess Technologies
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
Investors List
Taizhou Huayin Financial Investment
Taizhou Huayin Financial Investment investment in Series B - varnotech
Jincheng Capital
Jincheng Capital investment in Series B - varnotech
Shunxi Fund
Shunxi Fund investment in Series B - varnotech
3E Bioventures
3E Bioventures investment in Series B - varnotech
Beijing Jianxing Yiliao Jiankang Chanye Guquan Touzi Jijin
Beijing Jianxing Yiliao Jiankang Chanye Guquan Touzi Jijin investment in Series B - varnotech
Watere Capital
Watere Capital investment in Series B - varnotech
Legend Capital
Legend Capital investment in Series A - varnotech
IDG Capital
IDG Capital investment in Series A - varnotech
Watere Capital
Watere Capital investment in Seed Round - varnotech
Official Site Inspections
http://www.varnotech.com.cn
- Host name: 8.152.223.120
- IP address: 8.152.223.120
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "varnotech"
北京华诺泰生物医药科技有限公司
华诺泰成立于2019年，是一家具有自主知识产权的人用疫苗和创新佐剂研发及产业化的平台型公司。当前华诺泰已形成“一中心, 两基地”的集团化公司，北京为总部及研发中心，获得国家高新 …See details»
varnotech - Crunchbase Company Profile & Funding
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... varnotech …See details»
企业概况-北京华诺泰生物医药科技有限公司
华诺泰拥有新型佐剂技术、抗原筛选技术和病毒样颗粒技术等具有自主知识产权的技术平台，其中新型佐剂核心组分qs-21、3d-mla和新型脂质体佐剂，是国内唯一一家在符合gmp条件下完成 …See details»
Varnotech 2025 Company Profile: Valuation, Funding
Varnotech General Information Description. Provider and developer of vaccines and adjuvants designed to combat diseases and viruses. The company is committed in developing strong vaccines, antibodies, and adjuvants, enabling …See details»
Varnotech - VentureRadar
Mar 25, 2024 Varnotech is a Chinese biotech company specializing in the development of vaccines. They have secured significant investment for the acceleration of clinical trials for …See details»
Varnotech Biopharm Secures ¥600 Million in Series B Funding
Mar 28, 2024 Varnotech Biopharm, a leading innovative biotech company focused on vaccine research and development, has recently announced the successful completion of its Series B …See details»
varnotech - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 22, 2024: Series B - …See details»
华诺泰生物-动脉网 - vbdata.cn
北京华诺泰生物医药科技有限公司（以下简称“华诺泰”）于2019年1月注册成立，位于北京经济技术开发区，是一家致力于人用疫苗产品和创新佐剂研发及产业化的平台型公司。华诺泰拥有具有 …See details»
北京华诺泰生物科技有限公司 - 爱企查
爱企查为您提供北京华诺泰生物科技有限公司的企业信息查询服务，查询北京华诺泰生物科技有限公司工商注册信息、电话邮箱、公司地址、经营风险、控股持股、发展动态、财务状况、股东 …See details»
Varnotech - Qwika.Pro - Chinese Business Intelligence
Beijing Sinopep-Allsino Bio Pharmaceutical (Varnotech) Co., Ltd. (Varnotech), established in 2019, is dedicated to the research and development of human vaccine prodSee details»
Varnotech Biopharm - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number 010-59755366; Varnotech Biopharm engages in the research and development of human vaccine products and innovative …See details»
Chinese biotech firm Varnotech snaps $84m Series B funding
Mar 25, 2024 Vaccine developer Varnotech has secured 600 million yuan ($84 million) in a Series B round co-led by Beijing Pharmaceutical and Healthcare Industry Investment Fund, …See details»
Varnotech Biopharm - Funding, Financials, Valuation & Investors
Feb 1, 2020 Varnotech Biopharm engages in the research and development of human vaccine products and innovative adjuvants. New. Resources. Advanced Search. Start Free Trial . ...See details»
企业文化-北京华诺泰生物医药科技有限公司
勤奋是指企业不断努力和创新。疫苗的研发和生产是一个长期的过程，需要投入大量的人力、物力和财力。因此，企业需要保持高度的工作热情和动力，不断探索新的技术和方法，提高研发效 …See details»
Recombinant Multivalent Serogroup B Meningitis Subunit Vaccine …
Recombinant Multivalent Serogroup B Meningitis Subunit Vaccine (Varnotech), Initially developed by Beijing Huanuotai Biomedical Technology Co., Ltd., Now, its global highest R&D status is …See details»
联合创新实验室-北京华诺泰生物医药科技有限公司
为加速科学技术进步，增强企业的发展动力和技术创新能力，促进科研与生产相结合，将科技成果迅速转化为生产力，繁荣科技产业，实现优势互补，华诺泰集团与四川大学国家生物医学材料 …See details»
Series B - varnotech - 2024-03-22 - Crunchbase Funding Round …
Mar 25, 2024 varnotech raised $82997884 on 2024-03-22 in Series B. New. Resources. Advanced Search ... Funding Round. Series B - varnotech . Save . Summary. Overview. Edit …See details»
公司新闻-新闻中心-北京华诺泰生物医药科技有限公司
9月25日，华诺泰重组带状疱疹疫苗（cho细胞）Ⅱ期临床试验培训会于河北省正定县成功召开，并宣布将于10月初正式开展重组带状疱疹疫苗Ⅱ期临床入组工作。See details»
华诺泰重组带状疱疹疫苗、佐剂生产项目正式封顶-公司新闻-北京 …
Aug 23, 2024 8月22日，华诺泰重组带状疱疹疫苗、佐剂制剂生产车间主体结构正式封顶，预计年底可实现规模化生产。 作为华诺泰的疫苗生产基地，江苏华诺泰生物医药科技有限公司总 …See details»
Recombinant Zoster Vaccine (Varnotech) - Drug Targets, …
Recombinant Zoster Vaccine (Varnotech): a Immunostimulants Drug, Initially developed by Huanuotai Biomedical Technology (Chengdu) Co., Ltd., Now, its global highest R&D status is …See details»